Chronic kidney disease: Metformin increases risk of mortality in patients with advanced chronic kidney disease

Nature Reviews Nephrology

Volumn 11, Issue 8, 2015, Pages 443-

  Edwards, Jessica K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METFORMIN; ANTIDIABETIC AGENT;

CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; LACTIC ACIDOSIS; METABOLIC ACIDOSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETES MELLITUS, TYPE 2;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; RENAL INSUFFICIENCY, CHRONIC;

EID: 84938215127     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.110     Document Type: Note

References (2)

1. Hung S. C., et al. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study. Lancet Diabetes Endocrinol. doi: 10.1016/S2213- 8587(15)00123-0
2. Kalantar-Zadeh H. & Rhee C. M. Metformin in chronic kidney disease: more harm than help?. Lancet Diabetes Endocrinol. doi: 10.1016/S2213- 8587(15)00133-3